Rheumatology

 

Allopurinol Doesn’t Slow Kidney Disease

October 23, 2020

The gout treatment allopurinol doesn't appear to slow the progression of chronic kidney disease in patients with moderate to severe loss of kidney function, shows a study presented yesterday at the American Society of Nephrology Kidney Week annual meeting.

Early Results for New Gout Treatments Presented at Kidney Week

October 23, 2020

In today's featured video, we talk with Dr. Brad Marder, medical director at Horizon Therapeutics, who shares with us the details of three studies presented at the American Society of Nephrology annual meeting which is taking place this week online. The studies highlight the preliminary results of clinical trials for new gout treatments. In this interview, he explains why this research is important.

Rheumatology News Roundup: Kidney Week

October 23, 2020

In this week's news roundup from Rheumatology Network, we highlight studies presented at the American Society of Nephrology Kidney Week annual meeting taking place this week, including a study that shows the gout treatment allopurinol doesn’t slow kidney disease and another that estimates the annual cost of lupus nephritis at $50,000. These and other headlines are included in this week's news roundup.

Children Face Added Risks With Corticosteroid Use

October 22, 2020

Children who take oral corticosteroids for autoimmune conditions, such as juvenile arthritis, psoriasis, inflammatory bowel disease or other conditions, like asthma, have an increased risk of diabetes, high blood pressure, and blood clots, say researchers writing in the American Journal of Epidemiology.

Total Joint Surgery May Lower Fall Risk

October 22, 2020

A new study published in the Journal of the American Academy of Orthopaedic Surgeons shows that patients with advanced osteoarthritis who undergo total joint replacement, significantly lower their risk of falls after surgery as compared to patients who opt out of surgery.

Quiz: Rheumatic Disease Exercise Dos and Don'ts

October 21, 2020

Patients with rheumatic disease are encouraged to participate in regular exercise to reduce the impact of symptoms, such as osteoporosis, and also to protect against the development of other chronic conditions, in particular cardiovascular disease. But which specific symptoms can be improved, and what type of exercise is recommended and how much? Test your knowledge in this quiz.

Doctors Increasingly Skip the Exercise Lecture in Patient Clinic

October 21, 2020

Patients with inflammatory arthritis and osteoarthritis should be participating in four different types of exercise: cardiovascular, strength, flexibility, and balance. But a new study shows that patients are overly focused on cardiovascular exercise and not enough on exercise types designed to strengthen and protect joints and bones.

Workforce Shortage in Rheumatology Best Addressed on All Fronts

October 16, 2020

In this video, rheumatologist Vaneet Kaur Sandhu, M.D., addresses the workforce shortage in rheumatology. It should be addressed on all fronts, she says. If the workforce shortage doesn't turnaround patients in underserved areas will continue to be treated by physicians, albeit well-intended physicians, with little to no experience in rheumatic disease. Learn more in this interview.

Rheumatoid Arthritis With PTSD, Anxiety and Depression

October 16, 2020

Stress and anxiety can wreak havoc on one's health and hinder recovery, particularly for patients with chronic conditions, such as rheumatoid arthritis. In an article published online Sept. 13 in ACR Open Rheumatology, Joshua F. Baker, M.D., and colleagues report the results of study that finds veterans with rheumatoid arthritis and comorbid PTSD, depression, or anxiety, have poor persistence of methotrexate and TNFi therapies leading to worse outcomes. He addresses the study findings in this interview.